| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.09 |